Status:
COMPLETED
Safety and Efficacy of Stent Deployment for Intracranial Aneurysms (SESIA)
Lead Sponsor:
Zhujiang Hospital
Collaborating Sponsors:
Nanfang Hospital, Southern Medical University
Guangdong Provincial People's Hospital
Conditions:
Treatment Outcome by Stent-assisted Embolization
Eligibility:
All Genders
14-80 years
Brief Summary
Intracranial aneurysms (IA) regarded the third cause of cerebral vascular disease is the majoy cause of subarachnoid hemorrhage (SAH). The mortality and morbidity account for 22% to 25% in cerebrovasc...
Detailed Description
Studies showed 3.6% - 6% for the incidence and 1% - 2% for the ruptctued rate of IA.The mortality and morbidity account for 22% to 25% in cerebrovascular disease ,which is a growing trend. IA is one o...
Eligibility Criteria
Inclusion
- Subject has intracranial aneurysms confirmed by CT arteriography (CTA) or magnetic resonance angiography (MRA) or digital subtraction angiography(DSA)
- Subject has accepted stent - assisted embolization or flow-diversion treatment of intracranial aneurysm
Exclusion
- Subject has secondary intracranial aneurysms(e.g.traumatic aneurysm, infected aneurysm)
- Subject has received previous surgical clipping or endovascular treatment
- Subject has no intracranial aneurysms by DSA
- Subject with poor image quality
- Subject cannot use stent because of the small parent artery
- Subject do not need to use stent because of narrow-neck aneurysm
- History of aneurysm
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
4157 Patients enrolled
Trial Details
Trial ID
NCT03387995
Start Date
September 1 2016
End Date
August 30 2024
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ZhuJiang Hospital,Southern Medical University
Guangzhou, Guangdong, China, 510282